McKesson Corp. (MCK) News
Filter MCK News Items
MCK News Results
|Loading, please wait...|
MCK News Highlights
- MCK's 30 day story count now stands at 35.
- Over the past 26 days, the trend for MCK's stories per day has been choppy and unclear. It has oscillated between 1 and 7.
- ROSE, CAH and BRC are the most mentioned tickers in articles about MCK.
Latest MCK News From Around the Web
Below are the latest news stories about MCKESSON CORP that investors may wish to consider to help them evaluate MCK as an investment opportunity.
Investors are optimistic about AmerisourceBergen's (ABC) strength in its World Courier business.
The latest PMCF study demonstrates that Boston Scientific's (BSX) ACURATE neo2 Aortic Valve System is expected to significantly improve patient outcomes.
As a dividend growth investor, I am most focused on selecting great businesses with dependable profits. With a stake in the healthcare products distributor known as McKesson (NYSE: MCK) valued at $1.2 billion, the Oracle of Omaha seems to be impressed with the stock. Let's take a closer look at McKesson's fundamentals and valuation to address this question.
QIAGEN's (QGEN) latest multiplex test is expected to strengthen its portfolio and boost its fight against the global monkeypox outbreak.
Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on it.
Zacks.com featured highlights include Archer-Daniels-Midland, McKesson, ParkerHannifin, Booz Allen Hamilton and Darden Restaurants
Archer-Daniels-Midland, McKesson, ParkerHannifin, Booz Allen Hamilton and Darden Restaurants are part of the Zacks Screen of the Week article.
Major players in the healthcare distribution market are McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health Inc. , Owens & Minor Inc. , Morris and Dickson Co. LLC, KeySource Medical Inc. Major players in the healthcare distribution market are McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health Inc. , Owens & Minor Inc. , Morris and Dickson Co. LLC, KeySource Medical Inc.
Alcon's (ALC) ophthalmic pharmaceutical product suite is expected to be significantly boosted by adding new products following the recent acquisition.
Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversified product portfolio. However, the cost of products continues to rise.
Investors continue to be optimistic about QIAGEN (QGEN) on the back of a series of product launches.